Advanced Search

Technical Analysis for IVA - Inventiva S.A.

Grade Last Price % Change Price Change
grade A 14.105 2.96% 0.41
IVA closed up 2.96 percent on Tuesday, October 20, 2020, on 2.64 times normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical IVA trend table...
Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish 2.96%
Wide Range Bar Range Expansion 2.96%
Outside Day Range Expansion 2.96%
Wide Bands Range Expansion 2.96%
Overbought Stochastic Strength 2.96%
Upper Bollinger Band Touch Strength 2.96%
Older End-of-Day Gignals for IVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
3x Volume Pace about 13 hours ago
2x Volume Pace about 13 hours ago
1.5x Volume Pace about 13 hours ago
5x Volume Pace about 13 hours ago
Up 5% about 13 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Biology Gene Expression Therapy Hepatitis Non Alcoholic Fatty Liver Disease Fibrosis Small Molecule Therapies DNA Epigenetics Receptor

Is IVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Oct 20 Inventiva's odiparcil nabs accelerated review in U.S. for a rare genetic disorder
Oct 19 Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparci
Oct 13 The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
Oct 12 Inventiva nabs Breakthrough Device tag for its lead candidate for NASH
Sep 24 Inventiva to participate at several investor conferences in October 2020
Sep 17 Inventiva SA to Host Earnings Call
Sep 16 Inventiva reports 1H results
Sep 16 H1 2020 financial results and corporate business update
Sep 9 Inventiva to participate at several investor conferences in September 2020
Aug 12 Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
See more IVA news...

Indicators

Indicator Value
52 Week High 15.95
52 Week Low 9.01
Average Volume 28,972
200-Day Moving Average 0.00
50-Day Moving Average 12.18
20-Day Moving Average 12.75
10-Day Moving Average 13.74
Average True Range 0.68
ADX 24.74
+DI 26.11
-DI 22.24
Chandelier Exit (Long, 3 ATRs ) 12.85
Chandelier Exit (Short, 3 ATRs ) 13.11
Upper Bollinger Band 14.89
Lower Bollinger Band 10.61
Percent B (%b) 0.82
BandWidth 33.59
MACD Line 0.65
MACD Signal Line 0.52
MACD Histogram 0.1318
Fundamentals Value
Market Cap 541.33 Million
Num Shares 38.4 Million
EPS -1.32
Price-to-Earnings (P/E) Ratio -10.72
Price-to-Sales 52.91
Price-to-Book 10.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.08
Resistance 3 (R3) 15.10 14.80 14.92
Resistance 2 (R2) 14.80 14.55 14.79 14.86
Resistance 1 (R1) 14.45 14.40 14.30 14.43 14.81
Pivot Point 14.15 14.15 14.08 14.14 14.15
Support 1 (S1) 13.80 13.90 13.65 13.78 13.40
Support 2 (S2) 13.50 13.75 13.49 13.35
Support 3 (S3) 13.15 13.50 13.29
Support 4 (S4) 13.13